首页> 美国卫生研究院文献>Arrhythmia Electrophysiology Review >Arrhythmias in the Heart Transplant Patient
【2h】

Arrhythmias in the Heart Transplant Patient

机译:心脏移植患者的心律不齐

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Orthotopic heart transplantation (OHT) is currently the most effective long-term therapy for patients with end-stage cardiac disease, even as left ventricular devices show markedly improved outcomes. As surgical techniques and immunosuppressive regimens have been refined, short-term mortality caused by sepsis has decreased, while morbidity caused by repeated rejection episodes and vasculopathy has increased, and is often manifested by arrhythmias. These chronic transplant complications require early and aggressive multidisciplinary treatment. Understanding the relationship between arrhythmias and these complications in the acute and chronic stages following OHT is critical in improving patient prognosis, as arrhythmias may be the earliest or sole presentation. Finally, decentralised/ denervated hearts represent a unique opportunity to investigate the underlying mechanisms of arrhythmias.
机译:尽管左心室设备显示出明显改善的结局,但原位心脏移植(OHT)是目前对于晚期心脏病患者最有效的长期治疗方法。随着外科技术和免疫抑制方案的完善,由败血症引起的短期死亡率降低,而由反复排斥反应和血管病变引起的发病率增加,并且通常表现为心律不齐。这些慢性移植并发症需要早期和积极的多学科治疗。了解心律不齐与OHT术后急性和慢性阶段这些并发症之间的关系对于改善患者的预后至关重要,因为心律不齐可能是最早或唯一的表现。最后,去中心化/去神经化心脏代表了一个独特的机会来研究心律不齐的潜在机制。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号